(Q33980928)

30 July 2017

Correction of aberrant FGFR1 alternative RNA splicing through targeting of intronic regulatory elements (English)

1 reference

30 July 2017

Ivone G Bruno

1

1 reference

PubMed ID

15333583

30 July 2017

Wei Jin

series ordinal

2

1 reference

PubMed ID

15333583

30 July 2017

Gilbert J Cote

series ordinal

3

1 reference

30 July 2017

27 August 2004

1 reference

30 July 2017

Human Molecular Genetics

1 reference

30 July 2017

13

1 reference

30 July 2017

20

1 reference

30 July 2017

2409-2420

1 reference

Genome-wide survey of human alternative pre-mRNA splicing with exon junction microarrays

30 July 2017

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDH272

A genomic view of alternative splicing

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDH272

Alternative pre-mRNA splicing and proteome expansion in metazoans

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDH272

Alternative splicing: increasing diversity in the proteomic world

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDH272

RNA processing and the evolution of eukaryotes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDH272

Alternative splicing of pre-mRNA: developmental consequences and mechanisms of regulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDH272

Mechanisms of alternative pre-messenger RNA splicing

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDH272

Alternative pre-mRNA splicing: the logic of combinatorial control

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDH272

A protein interaction domain contacts RNA in the prespliceosome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDH272

Human Gene Mutation Database (HGMD): 2003 update.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDH272

Signals and their transduction pathways regulating alternative splicing: a new dimension of the human genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDH272

Pre-mRNA splicing and human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDH272

Alternately spliced NH2-terminal immunoglobulin-like Loop I in the ectodomain of the fibroblast growth factor (FGF) receptor 1 lowers affinity for both heparin and FGF-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDH272

Integrative nuclear FGFR1 signaling (INFS) as a part of a universal “feed‐forward‐and‐gate” signaling module that controls cell growth and differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDH272

Coordination of fibroblast growth factor receptor 1 (FGFR1) and fibroblast growth factor-2 (FGF-2) trafficking to nuclei of reactive astrocytes around cerebral lesions in adult rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDH272

Ligand activation of alternatively spliced fibroblast growth factor receptor-1 modulates pancreatic adenocarcinoma cell malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDH272

Differential expression of two fibroblast growth factor-receptor genes is associated with malignant progression in human astrocytomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDH272

Redundant intronic repressors function to inhibit fibroblast growth factor receptor-1 alpha-exon recognition in glioblastoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDH272

Messenger RNA reprogramming by spliceosome-mediated RNA trans-splicing

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDH272

Correction of disease-associated exon skipping by synthetic exon-specific activators

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDH272

Treatment of spinal muscular atrophy by sodium butyrate

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDH272

Aclarubicin treatment restores SMN levels to cells derived from type I spinal muscular atrophy patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDH272

Rescue of a human mRNA splicing defect by the plant cytokinin kinetin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDH272

Morpholino antisense oligonucleotide induced dystrophin exon 23 skipping in mdx mouse muscle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDH272

Reprogramming Alternative Pre-messenger RNA Splicing through the Use of Protein-binding Antisense Oligonucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDH272

A simple method for delivering morpholino antisense oligos into the cytoplasm of cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDH272

Identification of soluble forms of the fibroblast growth factor receptor in blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDH272

Restoration of human beta-globin gene expression in murine and human IVS2-654 thalassemic erythroid cells by free uptake of antisense oligonucleotides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDH272

Role and regulation of the fibroblast growth factor axis in human thyroid follicular cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDH272

Distinct sets of adjacent heterogeneous nuclear ribonucleoprotein (hnRNP) A1/A2 binding sites control 5' splice site selection in the hnRNP A1 mRNA precursor

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDH272

Modulation of exon skipping by high-affinity hnRNP A1-binding sites and by intron elements that repress splice site utilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDH272

Suppression of glioblastoma cell growth following antisense oligonucleotide-mediated inhibition of fibroblast growth factor receptor expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDH272

Progress in antisense technology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDH272

Modification of alternative splicing of Bcl-x pre-mRNA in prostate and breast cancer cells. analysis of apoptosis and cell death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDH272

Nuclear antisense effects of neutral, anionic and cationic oligonucleotide analogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDH272

Polypyrimidine tract binding protein antagonizes exon definition

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDH272

High-affinity hnRNP A1 binding sites and duplex-forming inverted repeats have similar effects on 5' splice site selection in support of a common looping out and repression mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDH272

The polypyrimidine tract binding protein binds upstream of neural cell-specific c-src exon N1 to repress the splicing of the intron downstream

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDH272

Alternatively spliced FGFR-1 isoform signaling differentially modulates endothelial cell responses to peroxynitrite

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDH272

Intronic sequences flanking alternatively spliced exons are conserved between human and mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDH272

Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDH272

21 January 2018

Identifiers

DOI

10.1093/HMG/DDH272

1 reference

30 July 2017

1 reference

PubMed ID

15333583